Drug Shortage Report for MAR-RIZATRIPTAN ODT
Report ID | 117425 |
Drug Identification Number | 02462796 |
Brand name | MAR-RIZATRIPTAN ODT |
Common or Proper name | Rizatriptan ODT |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | RIZATRIPTAN |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL ORAL |
Packaging size | 6 Tablets |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-06-10 |
Actual start date | 2020-06-10 |
Estimated end date | 2020-08-30 |
Actual end date | 2020-08-30 |
Shortage status | Resolved |
Updated date | 2020-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-08-31 | French | Compare |
v4 | 2020-08-31 | English | Compare |
v3 | 2020-06-11 | English | Compare |
v2 | 2020-06-10 | French | Compare |
v1 | 2020-06-10 | English | Compare |
Showing 1 to 5 of 5